• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ZOLL MANUFACTURING CORPORATION LIFEVEST WCD 4000 SYSTEM; WEARABLE CARDIOVERTER DEFIBRILLATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ZOLL MANUFACTURING CORPORATION LIFEVEST WCD 4000 SYSTEM; WEARABLE CARDIOVERTER DEFIBRILLATOR Back to Search Results
Model Number LIFEVEST WCD 4000 SYSTEM
Device Problems Over-Sensing (1438); Inappropriate/Inadequate Shock/Stimulation (1574)
Patient Problems Bradycardia (1751); Ventricular Fibrillation (2130); Shock from Patient Lead(s) (3162); Asystole (4442); Heart Block (4444)
Event Date 09/08/2022
Event Type  Death  
Manufacturer Narrative
The electrode belt and monitor have not been recovered.The device flag data from the last download does not indicate any device malfunction.
 
Event Description
A us distributor contacted zoll to report that a patient passed away on an unknown date while reportedly wearing the lifevest.The patient received two appropriate treatments, one which converted the arrhythmia to a slower rhythm and one which resulted in post shock asystole and two inappropriate treatments.  the device was started up at 09:19:51 on (b)(6) 2022.At 15:34:23, an arrhythmia was detected.Ecg shows vf.At 15:35:13, the patient received the first appropriate treatment.The rhythm at the time of treatment was vf.The post shock rhythm was sinus bradycardia from 25-50 bpm with hb.At 15:56:36, an arrhythmia was detected.Ecg shows vf.At 15:57:28, the patient received the second appropriate treatment.The rhythm at the time of treatment was vf.The post shock rhythm was asystole with intermittent cardiac activity.Post-shock asystole is a known and potentially adverse outcome of defibrillation therapy.At 15:58:20, the patient received the first inappropriate treatment.The patient was in a non-life sustaining rhythm prior to the treatment.Oversensing of cardiac activity contributed to the false detection.The rhythm at the time of treatment was asystole with intermittent cardiac activity.The post shock rhythm was asystole.At 15:58:47, the patient received the second inappropriate treatment.The patient was in a non-life sustaining rhythm prior to the treatment.Oversensing of cardiac activity contributed to the false detection.The rhythm at the time of treatment was asystole.The post shock rhythm was asystole with intermittent cardiac activity.The device was shut down at 1:04:44 on (b)(6) 2022.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LIFEVEST WCD 4000 SYSTEM
Type of Device
WEARABLE CARDIOVERTER DEFIBRILLATOR
Manufacturer (Section D)
ZOLL MANUFACTURING CORPORATION
121 gamma drive
pittsburgh PA 15238
Manufacturer (Section G)
ZOLL MANUFACTURING CORPORATION
121 gamma drive
pittsburgh PA
Manufacturer Contact
zoll mfg corporation
121 gamma drive
pittsburgh, PA 15238
MDR Report Key15464346
MDR Text Key300381355
Report Number3008642652-2022-23731
Device Sequence Number1
Product Code MVK
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P010030
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Distributor
Reporter Occupation Other
Type of Report Initial
Report Date 09/21/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Model NumberLIFEVEST WCD 4000 SYSTEM
Initial Date Manufacturer Received 09/17/2022
Initial Date FDA Received09/22/2022
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Patient Outcome(s) Death;
-
-